Latest News and Press Releases

Washington D.C., Feb. 18, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Roche to the Bio-Hermes-002 study. This collaboration will enhance this...

Winston Salem, NC, April 23, 2024 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, today announced the launch of GlucoseReady™, a fully integrated GCP compliant digital...

Winston Salem, NC, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, is expanding its patient engagement suite with the inclusion of the SPUR behavioral...

Winston Salem, NC, May 15, 2023 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, announces the publication of “Using a smartwatch and smartphone to assess early...

SAN FRANCISCO, May 09, 2023 (GLOBE NEWSWIRE) -- Feel Therapeutics, a leading digital precision medicine company, is proud to announce that it has been accepted into Johnson & Johnson...

PARIS, FRANCE, Feb. 28, 2023 (GLOBE NEWSWIRE) -- On Rare Disease Day, Ad Scientiam, a leader in digital biomarkers, announced the launch of two ambitious programs to develop and validate novel...

PARIS, FRANCE, Feb. 28, 2023 (GLOBE NEWSWIRE) -- On Rare Disease Day, Ad Scientiam, a leader in digital biomarkers, announced the launch of two ambitious programs to develop and validate novel...

Horsham, PA, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, has partnered with a leading biopharmaceutical organization focused on Parkinson’s Disease...

Horsham, PA, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Horsham, Pa.; December 14, 2022 — Clinical ink, a global life science technology company, has partnered with a leading biopharmaceutical organization...

SAN FRANCISCO, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Feel Therapeutics Inc., a leading company developing digital biomarkers and therapeutics to bring objective measurement and data in mental health,...